Citations (93)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Giorgio Costagliola, Susanna Cappelli & Rita Consolini. (2020) Behçet’s Disease in Children: Diagnostic and Management Challenges. Therapeutics and Clinical Risk Management 16, pages 495-507.
Read now
Read now
Ilknur Tugal-Tutkun & Pinar Çakar Özdal. (2020) Behçet’s disease uveitis: is there a need for new emerging drugs?. Expert Opinion on Emerging Drugs 25:4, pages 531-547.
Read now
Read now
Spyridon Koronis, Panagiotis Stavrakas, Miltiadis Balidis, Nikolaos Kozeis & Paris G Tranos. (2019) Update in treatment of uveitic macular edema. Drug Design, Development and Therapy 13, pages 667-680.
Read now
Read now
Uwe Pleyer, Dominika Pohlmann, Esra Kardeş, Denis Poddubnyy & Judith Rademacher. (2019) Emerging drugs for the treatment of noninfectious uveitis. Expert Opinion on Emerging Drugs 24:3, pages 173-190.
Read now
Read now
Caiyun You, Haitham F Sahawneh, Lina Ma, Buraa Kubaisi, Alexander Schmidt & C Stephen Foster. (2017) A review and update on orphan drugs for the treatment of noninfectious uveitis. Clinical Ophthalmology 11, pages 257-265.
Read now
Read now
Arash Maleki, Halea Meese, Haitham Sahawneh & C. Stephen Foster. (2016) Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis. Expert Review of Clinical Immunology 12:7, pages 775-786.
Read now
Read now
Antonio Vitale, Donato Rigante, Giuseppe Lopalco, Giacomo Emmi, Maria Teresa Bianco, Mauro Galeazzi, Florenzo Iannone & Luca Cantarini. (2016) New therapeutic solutions for Behçet’s syndrome. Expert Opinion on Investigational Drugs 25:7, pages 827-840.
Read now
Read now
Peykan Türkçüoğlu, Yonca Ozkan Arat, Emrah Kan, Elif Kılıç Kan, Imtiaz A. Chaudhry, Süleyman Koca, Ülkü Çeliker & Nevin İlhan. (2016) Association of Disease Activity with Serum and Tear IL-2 Levels in Behçet Disease. Ocular Immunology and Inflammation 24:3, pages 313-318.
Read now
Read now
Ina Kötter. (2015) The challenging treatment of Behcet’s disease. Expert Opinion on Orphan Drugs 3:10, pages 1101-1110.
Read now
Read now
Robert J Barry, Quan Dong Nguyen, Richard W Lee, Philip I Murray & Alastair K Denniston. (2014) Pharmacotherapy for uveitis: current management and emerging therapy. Clinical Ophthalmology 8, pages 1891-1911.
Read now
Read now
Sirichai Pasadhika & James T Rosenbaum. (2014) Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics: Targets and Therapy 8, pages 67-81.
Read now
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Expert Opinion on Biological Therapy 14:11, pages 1651-1666.
Read now
Read now
Manfred Zierhut, Ahmet M. Abu El-Asrar, Bahram Bodaghi & Ilknur Tugal-Tutkun. (2014) Therapy of Ocular Behçet Disease. Ocular Immunology and Inflammation 22:1, pages 64-76.
Read now
Read now
Anna Dastiridou, Christos Kalogeropoulos, Periklis Brazitikos, Chrysanthos Symeonidis & Sofia Androudi. (2012) New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment
. Expert Review of Clinical Pharmacology 5:5, pages 543-555.
Read now
Read now
Jangwon Heo, Yasir J Sepah, Jithin Yohannan, Morgan Renner, Abeer Akhtar, Anthony Gregory, Mathew Shulman, Diana V Do & Quan Dong Nguyen. (2012) The role of biologic agents in the management of non-infectious uveitis. Expert Opinion on Biological Therapy 12:8, pages 995-1008.
Read now
Read now
Theresa Larson, Robert B Nussenblatt & H Nida Sen. (2011) Emerging drugs for uveitis. Expert Opinion on Emerging Drugs 16:2, pages 309-322.
Read now
Read now
Houman D Hemmati & James P Dunn. (2010) Biologic therapy for uveitis. Expert Review of Ophthalmology 5:2, pages 225-239.
Read now
Read now
Izzet Fresko & Hasan Yazici. (2008) Treatment strategies for Behçet's disease. Expert Opinion on Pharmacotherapy 9:18, pages 3211-3219.
Read now
Read now
Samantha Fraser-Bell & Carlos Pavesio. (2008) Advances in the treatment of intermediate and posterior uveitis. Expert Review of Ophthalmology 3:4, pages 449-456.
Read now
Read now
Articles from other publishers (74)
Ezgi Deniz Batu, Seher Sener, Veysel Cam, Nuray Aktay Ayaz & Seza Ozen. (2023) Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data. BioDrugs 37:6, pages 813-828.
Crossref
Crossref
Jurgen Sota, Adriana Capuano, Giacomo Emmi, Florenzo Iannone, Luca Cantarini, Gulen Hatemi & Giuseppe Lopalco. (2023) Therapeutic approach to central nervous system involvement of Behçet's disease. Seminars in Arthritis and Rheumatism 61, pages 152206.
Crossref
Crossref
M. Joubert, A.-C. Desbois, F. Domont, A. Ghembaza, A. Lejoncour, A. Mirouse, G. Maalouf, M. Leclercq, S. Touhami, P. Cacoub, B. Bodaghi & D. Saadoun. (2023) Behçet's disease uveitis. La Revue de Médecine Interne.
Crossref
Crossref
Morgane Joubert, Anne-Claire Desbois, Fanny Domont, Amine Ghembaza, Alexandre Le Joncour, Adrien Mirouse, Georgina Maalouf, Mathilde Leclercq, Sarah Touhami, Patrice Cacoub, Bahram Bodaghi & David Saadoun. (2023) Behçet’s Disease Uveitis. Journal of Clinical Medicine 12:11, pages 3648.
Crossref
Crossref
Paola A. Rivera, Akash Gupta & Ninani Kombo. (2023) Treatment of non-infectious retinal vasculitis. Therapeutic Advances in Ophthalmology 15, pages 251584142311527.
Crossref
Crossref
Mi Zhang & Xiaomin Zhang. (2023) T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches. International Immunopharmacology 114, pages 109565.
Crossref
Crossref
George E. Fragoulis, George Bertsias, Bahram Bodaghi, Ahmet Gul, Jan van Laar, Gonca Mumcu, David Saadoun, Ilknur Tugal-Tutkun, Gulen Hatemi & Petros P. Sfikakis. (2023) Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?. Clinical Immunology 246, pages 109186.
Crossref
Crossref
Simple GuptaK. ShyamsundarMohini Agrawal, Nitin VichareJyotirmay Biswas. (2022) Current Knowledge of Biologics in Treatment of Noninfectious Uveitis. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 203-222.
Crossref
Crossref
Julie Gueudry, Mathilde Leclercq, David Saadoun & Bahram Bodaghi. (2021) Old and New Challenges in Uveitis Associated with Behçet’s Disease. Journal of Clinical Medicine 10:11, pages 2318.
Crossref
Crossref
Erkan Alpsoy, Pietro Leccese, Giacomo Emmi & Shigeaki Ohno. (2021) Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach. Frontiers in Medicine 8.
Crossref
Crossref
Kailei Guo & Xiaomin Zhang. (2021) Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. Journal of Immunology Research 2021, pages 1-19.
Crossref
Crossref
Thomas El Jammal, Olivier Loria, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Laurent Kodjikian & Pascal Sève. (2021) Uveitis as an Open Window to Systemic Inflammatory Diseases. Journal of Clinical Medicine 10:2, pages 281.
Crossref
Crossref
Alejandro Gómez-Gómez, Estíbaliz Loza, Mª Piedad Rosario, Gerard Espinosa, José M García Ruiz de Morales, José M Herrera, Santiago Muñoz-Fernández, Luis Rodríguez-Rodríguez & Miguel Cordero-Coma. (2020) Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review. Seminars in Arthritis and Rheumatism 50:6, pages 1299-1306.
Crossref
Crossref
Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, Georgina Maalouf, Sara Touhami, Patrice Cacoub, Bahram Bodaghi & David Saadoun. (2020) Biotherapies in Uveitis. Journal of Clinical Medicine 9:11, pages 3599.
Crossref
Crossref
Perpetual Uke, Rachel Gorodkin & Nicholas Beare. (2020) Biologic therapy for Behçet’s uveitis: a systematic review. British Journal of Ophthalmology 104:8, pages 1045-1051.
Crossref
Crossref
Clare E. Pain. (2020) Juvenile-onset Behçet's syndrome and mimics. Clinical Immunology 214, pages 108381.
Crossref
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis
326
349
.
Yılmaz Özyazgan & Ilknur Tugal-Tutkun. 2020. Behçet Syndrome. Behçet Syndrome
51
71
.
Vedat Hamuryudan, Ina Kötter & Hasan Tüzün. 2020. Behçet Syndrome. Behçet Syndrome
279
305
.
Mohammad Ali Shahab, Tahreem Aman Mir & Sidra Zafar. (2018) Optimising drug therapy for non-infectious uveitis. International Ophthalmology 39:7, pages 1633-1650.
Crossref
Crossref
Necmettin Akdeniz, Ömer Faruk Elmas & Ayşe Serap Karadağ. (2019) Behçet syndrome: A great imitator. Clinics in Dermatology 37:3, pages 227-239.
Crossref
Crossref
B. Bodaghi, D. Saadoun & P. Le Hoang. (2019) Prise en charge diagnostique et thérapeutique des uvéites. Bulletin de l'Académie Nationale de Médecine 203:3-4, pages 215-222.
Crossref
Crossref
Muhammad Hassan, Samendra Karkhur, Jeong H. Bae, Muhammad S. Halim, Maria S. Ormaechea, Neil Onghanseng, Nam V. Nguyen, Rubbia Afridi, Yasir J. Sepah, Diana V. Do & Quan D. Nguyen. (2019) New therapies in development for the management of non‐infectious uveitis: A review. Clinical & Experimental Ophthalmology 47:3, pages 396-417.
Crossref
Crossref
Ana Urruticoechea-Arana, Tatiana Cobo-Ibáñez, Virginia Villaverde-García, Montserrat Santos Gómez, Estíbaliz Loza, Kelly Vargas-Osorio, Leslie Fariñas Padrón, Federico Diaz-Gonzalez, Vanesa Calvo-Río & Ricardo Blanco. (2018) Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review. Rheumatology International 39:1, pages 47-58.
Crossref
Crossref
Julie Schallhorn. 2019. Posterior Uveitis. Posterior Uveitis
209
225
.
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis
175
207
.
Yesim Ozguler, Pietro Leccese, Robin Christensen, Sinem Nihal Esatoglu, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Çelik, Farida Fortune, Julien Gaudric, Ahmet Gul, Ina Kötter, Alfred Mahr, Robert J Moots, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri, Hasan Yazici & Gulen Hatemi. (2018) Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations. Rheumatology 57:12, pages 2200-2212.
Crossref
Crossref
Jurgen Sota, Donato Rigante, Giuseppe Lopalco, Bruno Frediani, Rossella Franceschini, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi, Claudia Fabiani & Luca Cantarini. (2017) Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review. Rheumatology International 38:1, pages 25-35.
Crossref
Crossref
Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston & Robert J. Barry. (2017) An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review. Orphanet Journal of Rare Diseases 12:1.
Crossref
Crossref
Hazel Squires, Edith Poku, Inigo Bermejo, Katy Cooper, John Stevens, Jean Hamilton, Ruth Wong, Alastair Denniston, Ian Pearce & Fahd Quhill. (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Health Technology Assessment 21:68, pages 1-170.
Crossref
Crossref
Radgonde Amer, Hilal Nalcı & Nilüfer Yalçındağ. (2017) Exudative retinal detachment. Survey of Ophthalmology 62:6, pages 723-769.
Crossref
Crossref
Alejandro Gómez-Gómez, Estíbaliz Loza, Maria Piedad Rosario, Gerard Espinosa, José M. García Ruiz de Morales, Jose M. Herreras, Santiago Muñoz-Fernández & Miguel Cordero-Coma. (2017) Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis. Medicine 96:42, pages e8045.
Crossref
Crossref
Isil Bulur & Meltem Onder. (2017) Behçet disease: New aspects. Clinics in Dermatology 35:5, pages 421-434.
Crossref
Crossref
Fahd Adeeb, Austin G. Stack & Alexander D. Fraser. (2017) Knitting the Threads of Silk through Time: Behçet’s Disease—Past, Present, and Future. International Journal of Rheumatology 2017, pages 1-13.
Crossref
Crossref
Christos C. Zouboulis. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
12
.
Erkan Alpsoy. (2016) Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. The Journal of Dermatology 43:6, pages 620-632.
Crossref
Crossref
Bianka Sobolewska, Deshka Doycheva, Christoph Deuter & Manfred Zierhut. 2016. Uveitis: An Update. Uveitis: An Update
33
42
.
Sumru Onal & Ilknur Tugal-Tutkun. 2016. Uveitis: An Update. Uveitis: An Update
17
31
.
Sofia Androudi, Anna Dastiridou & Manfred Zierhut. 2016. Intraocular Inflammation. Intraocular Inflammation
385
397
.
John Anthonypillai & Julian L. Ambrus. 2016. Systemic Vasculitides: Current Status and Perspectives. Systemic Vasculitides: Current Status and Perspectives
407
423
.
Giulia Pazzola, Francesco Muratore, Nicolò Pipitone & Carlo Salvarani. (2015) Biologics in vasculitides: Where do we stand, where do we go from now?. La Presse Médicale 44:6, pages e231-e239.
Crossref
Crossref
E. Feurer, P. Bielefeld, D. Saadoun & P. Sève. (2015) Uvéites et biothérapies. La Revue de Médecine Interne 36:2, pages 107-116.
Crossref
Crossref
Jane S. Kim, Jared E. Knickelbein, Robert B. Nussenblatt & H. Nida Sen. (2015) Clinical Trials in Noninfectious Uveitis. International Ophthalmology Clinics 55:3, pages 79-110.
Crossref
Crossref
Nadim Mahmud, Burcin Taner & Nasimul Ahsan. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
1375
1404
.
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub & David Saadoun. (2014) Biotherapies in Behçet's disease. Autoimmunity Reviews 13:7, pages 762-769.
Crossref
Crossref
C. Comarmond, B. Wechsler, P. Cacoub & D. Saadoun. (2014) Traitement de la maladie de Behçet. La Revue de Médecine Interne 35:2, pages 126-138.
Crossref
Crossref
Un Chul Park, Tae Wan Kim & Hyeong Gon Yu. (2014) Immunopathogenesis of Ocular Behçet’s Disease. Journal of Immunology Research 2014, pages 1-13.
Crossref
Crossref
Alastair K Denniston & Andrew D Dick. (2013) Systemic therapies for inflammatory eye disease: Past, Present and Future. BMC Ophthalmology 13:1.
Crossref
Crossref
Cloé Comarmond, Bertrand Wechsler, Patrice Cacoub & David Saadoun. (2013) Approaches to immunosuppression in Behçet’s disease. Immunotherapy 5:7, pages 743-754.
Crossref
Crossref
D. Saadoun, B. Bodaghi, B. Bienvenu, B. Wechsler, D. Sene, S. Trad, S. Abad, P. Cacoub, L. Kodjikian & P. Sève. (2013) Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies. Autoimmunity Reviews 12:7, pages 774-783.
Crossref
Crossref
A.L. Catapano & N. Papadopoulos. (2013) The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway. Atherosclerosis 228:1, pages 18-28.
Crossref
Crossref
Andrew D. Dick, Ilknur Tugal-Tutkun, Stephen Foster, Manfred Zierhut, S.H. Melissa Liew, Vladimir Bezlyak & Sofia Androudi. (2013) Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials. Ophthalmology 120:4, pages 777-787.
Crossref
Crossref
Joerg-Patrick Stübgen. (2012) Targeted immunotherapy trials for idiopathic inflammatory myopathies. Journal of Neurology 260:2, pages 368-385.
Crossref
Crossref
Masaru Takeuchi. (2013) A systematic review of biologics for the treatment of noninfectious uveitis. Immunotherapy 5:1, pages 91-102.
Crossref
Crossref
Katherine Buzzard, Simon Broadley & Helmut Butzkueven. (2012) What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?. International Journal of Molecular Sciences 13:12, pages 12665-12709.
Crossref
Crossref
C.M.E. Deuter, M. Zierhut, D. Doycheva & I. Kötter. (2012) Therapie des Morbus Behçet gestern und heuteTreatment of Behçet’s disease yesterday and today. Der Ophthalmologe 109:6, pages 568-574.
Crossref
Crossref
Roland Martin. (2012) Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis. Clinical Immunology 142:1, pages 9-14.
Crossref
Crossref
Khayyam Durrani, Fouad R. Zakka, Muna Ahmed, Mohiuddin Memon, Sana S. Siddique & C. Stephen Foster. (2011) Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease. Survey of Ophthalmology 56:6, pages 474-510.
Crossref
Crossref
Johannes Nowatzky & Yusuf Yazici. (2011) Current management of Behçet's syndrome. Drug Development Research 72:7, pages 647-656.
Crossref
Crossref
Keith Wroblewski, H. Nida Sen, Steven Yeh, Lisa Faia, Zhuging Li, Pushpa Sran, Sapna Gangaputra, Susan Vitale, Patti Sherry & Robert Nussenblatt. (2011) Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease. Canadian Journal of Ophthalmology 46:4, pages 322-328.
Crossref
Crossref
Esperanza Pato, Santiago Muñoz-Fernández, Félix Francisco, Miguel A. Abad, Jesús Maese, Ana Ortiz & Loreto Carmona. (2011) Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis. Seminars in Arthritis and Rheumatism 40:4, pages 314-323.
Crossref
Crossref
Arnd Heiligenhaus, Stephan Thurau, Maren Hennig, Rafael S. Grajewski & Gerhild Wildner. (2010) Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefe's Archive for Clinical and Experimental Ophthalmology 248:11, pages 1531-1551.
Crossref
Crossref
Robert B. Nussenblatt. 2010. Uveitis. Uveitis
332
354
.
Yılmaz Özyazgan & Bahram Bodaghi. 2010. Behçet’s Syndrome. Behçet’s Syndrome
73
94
.
Vedat Hamuryudan & Ina Kötter. 2010. Behçet’s Syndrome. Behçet’s Syndrome
317
338
.
Srilakshmi M. Sharma, Andrew D. Dick & Athimalaipet V. Ramanan. (2009) Non-Infectious Pediatric Uveitis. Pediatric Drugs 11:4, pages 229-241.
Crossref
Crossref
H. Nida Sen, Amit Sangave, Keri Hammel, Grace Levy-Clarke & Robert B. Nussenblatt. (2009) Infliximab for the treatment of active scleritis. Canadian Journal of Ophthalmology 44:3, pages e9-e12.
Crossref
Crossref
Edsel Maurice T. Salvana & Robert A. Salata. (2009) Infectious Complications Associated with Monoclonal Antibodies and Related Small Molecules. Clinical Microbiology Reviews 22:2, pages 274-290.
Crossref
Crossref
William W. Busse, Elliot Israel, Harold S. Nelson, James W. Baker, B. Lauren Charous, Donald Y. Young, Vladimir Vexler & Richard S. Shames. (2008) Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma. American Journal of Respiratory and Critical Care Medicine 178:10, pages 1002-1008.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Ophthalmology 19:6, pages 541-548.
Crossref
Crossref
Aliza Jap & Soon-Phaik Chee. (2008) Immunosuppressive therapy for ocular diseases. Current Opinion in Ophthalmology 19:6, pages 535-540.
Crossref
Crossref
Sebahattin Yurdakul & Hasan Yazici. (2008) Behçet's syndrome. Best Practice & Research Clinical Rheumatology 22:5, pages 793-809.
Crossref
Crossref
Steven Yeh, Keith Wroblewski, Ronald Buggage, Zhuqing Li, Shree K. Kurup, Hatice Nida Sen, Sam Dahr, Pushpa Sran, George F. Reed, Randy Robinson, Jack A. Ragheb, Thomas A. Waldmann & Robert B. Nussenblatt. (2008) High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. Journal of Autoimmunity 31:2, pages 91-97.
Crossref
Crossref
Kira Michalova & Lyndell Lim. (2008) Biologic agents in the management of inflammatory eye diseases. Current Allergy and Asthma Reports 8:4, pages 339-347.
Crossref
Crossref